发明名称 TREPROSTINIL ADMINISTRATION USING METERED DOSE INHALER
摘要 PROBLEM TO BE SOLVED: To provide a therapeutic method for pulmonary hypertension and to provide a related kit.SOLUTION: The invention relates to a pharmaceutical formulation for treating pulmonary hypertension in a human using a pressurized metered dose inhaler, which contains treprostinil or an acid derivative thereof or a pharmaceutically acceptable salt thereof and which is used to deliver the treprostinil or an acid derivative thereof or a pharmaceutically acceptable salt thereof with a pulsed ultrasonic nebulizer, the pharmaceutical formulation being a solution. The concentration of treprostinil or an acid derivative thereof or a pharmaceutically acceptable salt thereof in the solution is in the range of 500 to 2500 μg/ml. The acid derivative is selected from a C-alkyl ester and amide of treprostinil (in the amide, nitrogen is optionally substituted by one or two C-4 alkyl groups).
申请公布号 JP2016006066(A) 申请公布日期 2016.01.14
申请号 JP20150142794 申请日期 2015.07.17
申请人 UNITED THERAPEUTICS CORP 发明人 HORST OLSCHEWSKI;ROBERT ROSCIGNO;LEWIS J RUBIN;THOMAS SCHMEHL;WERNER SEEGER;CARL STERRITT;ROBERT VOSWINCKEL
分类号 A61K31/19;A61K9/08;A61K9/72;A61K47/10;A61M11/00;A61P9/12 主分类号 A61K31/19
代理机构 代理人
主权项
地址